Phenytoin / Fosphenytoin
Brand names: Epanutin (phenytoin), Pro-Epanutin (fosphenytoin)
Phenytoin is an antiepileptic used for focal and generalised tonic-clonic seizures and for status epilepticus; fosphenytoin is a prodrug used when a faster, better-tolerated infusion is needed.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It blocks voltage-gated sodium channels to stabilise neuronal membranes.
Prescribing in practice
- It has a narrow therapeutic index and non-linear (saturable) kinetics — small dose changes cause large level changes, so titrate carefully with level monitoring (interpreted alongside albumin).
- Intravenous loading must be given at a controlled rate with cardiac monitoring (risk of hypotension, arrhythmia and tissue injury).
- It is a strong enzyme inducer with many interactions; long-term use causes gum overgrowth; it is teratogenic.
Monitoring
Monitor phenytoin levels (corrected for albumin), ECG and blood pressure during IV loading, and FBC/LFTs; review interactions.
Counselling the patient
- Take it consistently; do not change brand or stop without advice.
- Keep good oral hygiene to reduce gum overgrowth.
- Report rash, unusual bruising, or yellowing of the skin/eyes.
Evidence & guidelines
Used for tonic-clonic seizures and as a second-line agent in status epilepticus, with strict level monitoring and IV-administration safeguards.
Reference: NICE NG217 (Epilepsy); APLS Guidelines; RCPCH Status Epilepticus Pathway; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- ASA Physical Status Classification · Perioperative Risk
- Duke Activity Status Index (DASI) · Functional Assessment
- ECOG / WHO Performance Status · Performance Status
- Karnofsky Performance Status Scale · Performance Status
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014)
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC
Featured in these MRCEM clinical pathways
Phenytoin / Fosphenytoin is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.